Inovio

$2.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (+6.14%) As of 2:57 PM EST today
+$0.14 (+6.14%) Today

Why Robinhood?

You can buy or sell Inovio and other stocks, options, ETFs, and crypto commission-free!

About INO

Inovio Pharmaceuticals, Inc. Common Stock, also called Inovio, is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Read More Its drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Employees
281
Headquarters
Plymouth Meeting, Pennsylvania
Founded
1983
Market Cap
228.02M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.07M
High Today
$2.53
Low Today
$2.27
Open Price
$2.27
Volume
623.70K
52 Week High
$5.47
52 Week Low
$1.92

Collections

INO News

ReutersNov 13

Edited Transcript of INO earnings conference call or presentation 12-Nov-19 9:30pm GMT

Q3 2019 Inovio Pharmaceuticals Inc Earnings Call BLUE BELL Nov 13, 2019 (Thomson StreetEvents) -- Edited Transcript of Inovio Pharmaceuticals Inc earnings conf
5

INO Earnings

-$0.36
-$0.27
-$0.17
-$0.08
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Available Nov 12, After Hours

You May Also Like

Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.